MedPath

Gated 13N-NH3 PET before and during hemodialysis for the assessment of changes in myocardial perfusion, volumes and output of the left ventricle

Conditions
Hemodialysis patients
Registration Number
EUCTR2006-000867-27-NL
Lead Sponsor
niversity Medical Center Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
8
Inclusion Criteria

Adult (age above 18) HD patients who have been treated with HD for at least six months. Patients must have an arterio-venous fistula without recirculation established by Transonic flow measurements.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1. The absence of informed consent (see ethical considerations) 2. The need to perform HD with pre-dilution. 3. Recent haemorrhage. 4. Unstable angina pectoris. 5. History of myocardial infarction. 6. Inability to endure a horizontal position for a longer period of time. 7. Arrhythmia. 8. The use of long-acting nitrates. 9. Left ventricular ejection fraction = 30%. 10. Diabetes Mellitus. 11. Pregnancy or suspicion hereof.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath